Release Date: 30/04/10 17:17 Summary: March Quarter Cash Flow Report Price Sensitive: Yes Download Document 132.4KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%